Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement-Reference-Cited by-同舟云学术

Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement

Published:2021-05 Issue: Volume:Volume 16 Page:1215-1226
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Vogelmeier Claus F,Naya Ian P,Maltais François^ORCID,Bjermer Leif^ORCID,Kerwin Edward M^ORCID,Tombs Lee,Jones Paul W^ORCID,Compton Chris,Lipson David A^ORCID,Boucot Isabelle H^ORCID

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pulmonary and Respiratory Medicine,General Medicine

Reference22 articles.

1. Lung function decline in COPD

New insights into early intervention of chronic obstructive pulmonary disease with mild airflow limitation

3. Management of Chronic Obstructive Pulmonary Disease

4. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial

5. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2021. Accessed January 2021.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tiotropium reduces clinically important deterioration in patients with mild-to-moderate chronic obstructive pulmonary disease: A post hoc analysis of the Tie-COPD study;Respiratory Medicine;2024-02

2. An Update on Outcomes for COPD Pharmacological Trials: A COPD Investigators Report - Reassessment of the 2008 American Thoracic Society/European Respiratory Society Statement on Outcomes for COPD Pharmacological Trials;American Journal of Respiratory and Critical Care Medicine;2023-08-15

3. The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease;Respiratory Research;2023-03-30

4. How can the findings of the EMAX trial on long-acting bronchodilation in chronic obstructive pulmonary disease be applied in the primary care setting?;Chronic Respiratory Disease;2023-01

5. Pharmacotherapy of LAMA/LABA inhaled therapy combinations for chronic obstructive pulmonary disease: a clinical overview;Expert Review of Clinical Pharmacology;2022-11-02